Does ORITAVANCIN Cause Agranulocytosis? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Agranulocytosis have been filed in association with ORITAVANCIN (Orbactiv). This represents 1.1% of all adverse event reports for ORITAVANCIN.
10
Reports of Agranulocytosis with ORITAVANCIN
1.1%
of all ORITAVANCIN reports
0
Deaths
10
Hospitalizations
How Dangerous Is Agranulocytosis From ORITAVANCIN?
Of the 10 reports, 10 (100.0%) required hospitalization, and 1 (10.0%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ORITAVANCIN. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does ORITAVANCIN Cause?
Off label use (174)
Pruritus (163)
Urticaria (106)
Back pain (85)
Rash (84)
Chills (82)
Dyspnoea (72)
Nausea (66)
Infusion related reaction (62)
Erythema (59)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which ORITAVANCIN Alternatives Have Lower Agranulocytosis Risk?
ORITAVANCIN vs ORITAVANCIN DIPHOSPHATE
ORITAVANCIN vs ORLISTAT
ORITAVANCIN vs ORNIDAZOLE
ORITAVANCIN vs ORPHENADRINE
ORITAVANCIN vs OSELTAMIVIR